Literature DB >> 19366831

Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.

Liesel M Fitzgerald1, Erika M Kwon, Joseph S Koopmeiners, Claudia A Salinas, Janet L Stanford, Elaine A Ostrander.   

Abstract

PURPOSE: Two recent genome-wide association studies have highlighted several single nucleotide polymorphisms (SNPs) purported to be associated with prostate cancer risk. We investigated the significance of these SNPs in a population-based study of Caucasian men, testing the effects of each SNP in relation to family history of prostate cancer and the clinicopathologic features of the disease. EXPERIMENTAL
DESIGN: We genotyped 13 SNPs in 1,308 prostate cancer patients and 1,267 unaffected controls frequency matched to cases by five-year age groups. The association of each SNP with disease risk stratified by family history of prostate cancer and clinicopathologic features of the disease was calculated with the use of logistic and polytomous regression.
RESULTS: These results confirm the importance of multiple, previously reported SNPs in relation to prostate cancer susceptibility; 11 of the 13 SNPs were significantly associated with risk of developing prostate cancer. However, none of the SNP associations were of comparable magnitude with that associated with having a first-degree family history of the disease. Risk estimates associated with SNPs rs4242382 and rs2735839 varied by family history, whereas risk estimates for rs10993994 and rs5945619 varied by Gleason score.
CONCLUSIONS: Our results confirm that several recently identified SNPs are associated with prostate cancer risk; however, the variant alleles only confer a low to moderate relative risk of disease and are generally not associated with more aggressive disease features.

Entities:  

Mesh:

Year:  2009        PMID: 19366831      PMCID: PMC2707085          DOI: 10.1158/1078-0432.CCR-08-2190

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  35 in total

1.  A common variant associated with prostate cancer in European and African populations.

Authors:  Laufey T Amundadottir; Patrick Sulem; Julius Gudmundsson; Agnar Helgason; Adam Baker; Bjarni A Agnarsson; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Jean-Baptiste Cazier; Jesus Sainz; Margret Jakobsdottir; Jelena Kostic; Droplaug N Magnusdottir; Shyamali Ghosh; Kari Agnarsson; Birgitta Birgisdottir; Louise Le Roux; Adalheidur Olafsdottir; Thorarinn Blondal; Margret Andresdottir; Olafia Svandis Gretarsdottir; Jon T Bergthorsson; Daniel Gudbjartsson; Arnaldur Gylfason; Gudmar Thorleifsson; Andrei Manolescu; Kristleifur Kristjansson; Gudmundur Geirsson; Helgi Isaksson; Julie Douglas; Jan-Erik Johansson; Katarina Bälter; Fredrik Wiklund; James E Montie; Xiaoying Yu; Brian K Suarez; Carole Ober; Kathleen A Cooney; Henrik Gronberg; William J Catalona; Gudmundur V Einarsson; Rosa B Barkardottir; Jeffrey R Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2006-05-07       Impact factor: 38.330

2.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

Authors:  Matthew L Freedman; Christopher A Haiman; Nick Patterson; Gavin J McDonald; Arti Tandon; Alicja Waliszewska; Kathryn Penney; Robert G Steen; Kristin Ardlie; Esther M John; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

3.  Multiple regions within 8q24 independently affect risk for prostate cancer.

Authors:  Christopher A Haiman; Nick Patterson; Matthew L Freedman; Simon R Myers; Malcolm C Pike; Alicja Waliszewska; Julie Neubauer; Arti Tandon; Christine Schirmer; Gavin J McDonald; Steven C Greenway; Daniel O Stram; Loic Le Marchand; Laurence N Kolonel; Melissa Frasco; David Wong; Loreall C Pooler; Kristin Ardlie; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Esther M John; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

4.  Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.

Authors:  Liang Wang; Shannon K McDonnell; Joshua P Slusser; Scott J Hebbring; Julie M Cunningham; Steven J Jacobsen; James R Cerhan; Michael L Blute; Daniel J Schaid; Stephen N Thibodeau
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study.

Authors:  Gianluca Severi; Vanessa M Hayes; Emma J D Padilla; Dallas R English; Melissa C Southey; Robert L Sutherland; John L Hopper; Graham G Giles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

6.  A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis.

Authors:  Sylvie Lamy; Marcia T Ruiz; Jan Wisniewski; Seema Garde; Shafaat A Rabbani; Chandra Panchal; Jinzi J Wu; Borhane Annabi
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

7.  A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis.

Authors:  Borhane Annabi; Mounia Bouzeghrane; Jean-Christophe Currie; Robert Hawkins; Hélène Dulude; Luc Daigneault; Marcia Ruiz; Jan Wisniewski; Seema Garde; Shafaat A Rabbani; Chandra Panchal; Jinzi J Wu; Richard Béliveau
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

8.  A common 8q24 variant in prostate and breast cancer from a large nested case-control study.

Authors:  Fredrick R Schumacher; Heather Spencer Feigelson; David G Cox; Christopher A Haiman; Demetrius Albanes; Julie Buring; Eugenia E Calle; Stephen J Chanock; Graham A Colditz; W Ryan Diver; Alison M Dunning; Matthew L Freedman; John M Gaziano; Edward Giovannucci; Sue E Hankinson; Richard B Hayes; Brian E Henderson; Robert N Hoover; Rudolf Kaaks; Timothy Key; Laurence N Kolonel; Peter Kraft; Loic Le Marchand; Jing Ma; Malcolm C Pike; Elio Riboli; Meir J Stampfer; Daniel O Stram; Gilles Thomas; Michael J Thun; Ruth Travis; Jarmo Virtamo; Gerald Andriole; Edward Gelmann; Walter C Willett; David J Hunter
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

9.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.

Authors:  Meredith Yeager; Nick Orr; Richard B Hayes; Kevin B Jacobs; Peter Kraft; Sholom Wacholder; Mark J Minichiello; Paul Fearnhead; Kai Yu; Nilanjan Chatterjee; Zhaoming Wang; Robert Welch; Brian J Staats; Eugenia E Calle; Heather Spencer Feigelson; Michael J Thun; Carmen Rodriguez; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Edward Giovannucci; Walter C Willett; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; Edward P Gelmann; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert Hoover; David J Hunter; Stephen J Chanock; Gilles Thomas
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

10.  Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis.

Authors:  S V Garde; V S Basrur; L Li; M A Finkelman; A Krishan; L Wellham; E Ben-Josef; M Haddad; J D Taylor; A T Porter; D G Tang
Journal:  Prostate       Date:  1999-02-01       Impact factor: 4.104

View more
  33 in total

1.  Genetic variation at chromosome 8q24 in osteosarcoma cases and controls.

Authors:  Lisa Mirabello; Sonja I Berndt; Guillermo F Seratti; Laurie Burdett; Meredith Yeager; Salma Chowdhury; Kedest Teshome; Arinze Uzoka; Chester Douglass; Richard B Hayes; Robert N Hoover; Sharon A Savage
Journal:  Carcinogenesis       Date:  2010-06-07       Impact factor: 4.944

2.  Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.

Authors:  Fang-Chi Hsu; Jielin Sun; Yi Zhu; Seong-Tae Kim; Tao Jin; Zheng Zhang; Fredrik Wiklund; A Karim Kader; S Lilly Zheng; William Isaacs; Henrik Grönberg; Jianfeng Xu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

3.  Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.

Authors:  Jielin Sun; A Karim Kader; Fang-Chi Hsu; Seong-Tae Kim; Yi Zhu; Aubrey R Turner; Tao Jin; Zheng Zhang; Jan Adolfsson; Fredrik Wiklund; S Lilly Zheng; William B Isaacs; Henrik Grönberg; Jianfeng Xu
Journal:  Prostate       Date:  2010-09-28       Impact factor: 4.104

4.  Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer.

Authors:  Stella Koutros; Laura E Beane Freeman; Sonja I Berndt; Gabriella Andreotti; Jay H Lubin; Dale P Sandler; Jane A Hoppin; Kai Yu; Qizhai Li; Laura A Burdette; Jeffrey Yuenger; Meredith Yeager; Michael C R Alavanja
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

5.  NUDT11 rs5945572 polymorphism and prostate cancer risk: a meta-analysis.

Authors:  Wencheng Li; Min Gu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Common variants at 8q24 are associated with prostate cancer risk in Serbian population.

Authors:  Ana S Branković; Goran N Brajušković; Jovan D Mirčetić; Zorana Z Nikolić; Predrag B Kalaba; Vinka D Vukotić; Saša M Tomović; Snežana J Cerović; Zoran A Radojičić; Dušanka L J Savić-Pavićević; Stanka P Romac
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

7.  Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

Authors:  Jianfeng Xu; Siqun Lilly Zheng; Sarah D Isaacs; Kathleen E Wiley; Fredrik Wiklund; Jielin Sun; A Karim Kader; Ge Li; Lina D Purcell; Seong-Tae Kim; Fang-Chi Hsu; Pär Stattin; Jonas Hugosson; Jan Adolfsson; Patrick C Walsh; Jeffrey M Trent; David Duggan; John Carpten; Henrik Grönberg; William B Isaacs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

8.  Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.

Authors:  Wendy J Langeberg; Erika M Kwon; Joseph S Koopmeiners; Elaine A Ostrander; Janet L Stanford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

9.  8q24 sequence variants in relation to prostate cancer risk among men of African descent: a case-control study.

Authors:  Marnita L Benford; Tiva T VanCleave; Nicole A Lavender; Rick A Kittles; LaCreis R Kidd
Journal:  BMC Cancer       Date:  2010-06-28       Impact factor: 4.430

10.  Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.

Authors:  Mark M Pomerantz; Yashaswi Shrestha; Richard J Flavin; Meredith M Regan; Kathryn L Penney; Lorelei A Mucci; Meir J Stampfer; David J Hunter; Stephen J Chanock; Eric J Schafer; Jennifer A Chan; Josep Tabernero; José Baselga; Andrea L Richardson; Massimo Loda; William K Oh; Philip W Kantoff; William C Hahn; Matthew L Freedman
Journal:  PLoS Genet       Date:  2010-11-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.